Company / Debt per Share
BIOCRYST PHARMACEUTICALS INC Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
-
FY2025
5-year range
$0.00 / $1.66
FY2021-FY2025
Trend
-100.0%
vs FY2024
Sector context
#80 of 82
Health Care
What the data says
Improved from $1.58 to $0.00 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 82
▼
Key checks
Key Insights
- In FY2025, debt per share decreased 100.0% year-over-year.
- Peak debt per share was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | -100.0% |
| FY2024 | $1.52 | -3.4% |
| FY2023 | $1.58 | +26.6% |
| FY2022 | $1.25 | -25.1% |
| FY2021 | $1.66 | +127.1% |
| FY2020 | $0.73 | - |
| FY2019 | $0.00 | -100.0% |
| FY2018 | $0.29 | -6.7% |
| FY2017 | $0.31 | -0.6% |
| FY2016 | $0.31 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026